Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Oral minoxidil helps with hair growth but needs more research to fully understand its effectiveness and safety.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Oral minoxidil significantly reduces hair shedding in women with chronic telogen effluvium.

The document concludes that personalized treatment plans for hair loss in Asian men are necessary and more research is needed to develop effective guidelines.

Most women with hirsutism have normal hormone levels and can be treated with cosmetic methods; obesity and PCOS are common causes, and treatments depend on the underlying issue.

Early diagnosis and personalized treatment are crucial for managing hair loss in children.

Low-level laser therapy is safe but not significantly better than minoxidil alone for hair growth.

The hemp extract significantly increased hair regrowth in both men and women without any side effects.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Hormonal treatments can effectively improve hidradenitis suppurativa symptoms.

Most dermatology drugs in Denmark are used correctly, with few unusual patterns.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Current treatments for androgenetic alopecia are complex and promising, but more research is needed.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

New treatments using stem cells and other methods show promise for promoting hair growth in androgenetic alopecia.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Spironolactone has the most side effects, including serious risks, while eplerenone and finerenone mainly affect the heart, kidneys, and metabolism.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Stress affects skin health, and mental health support is crucial for patients with skin conditions.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

PRP improves hair transplant results in androgenetic alopecia patients.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

The Sinclair Shedding Scale is effective for diagnosing Alopecia Areata Incognita and monitoring treatment success.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.